🇺🇸 FDA
Patent

US 10166285

Recombinant virus with diminished latency and methods of using same

granted A61KA61K2039/5254A61K39/12

Quick answer

US patent 10166285 (Recombinant virus with diminished latency and methods of using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/5254, A61K39/12, A61K39/245, A61K39/25